Serge Bologna

4.1k total citations
38 papers, 1.4k citations indexed

About

Serge Bologna is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Serge Bologna has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 15 papers in Genetics. Recurrent topics in Serge Bologna's work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Lung Cancer Treatments and Mutations (8 papers). Serge Bologna is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Lung Cancer Treatments and Mutations (8 papers). Serge Bologna collaborates with scholars based in France, Belgium and Luxembourg. Serge Bologna's co-authors include Olivier Casasnovas, Corinne Haïoun, Bertrand Coiffier, Nicolas Mounier, Hervé Tilly, Josette Brière, Anne Sonet, Catherine Thiéblemont, Franck Morschhauser and Hervé Ghesquières and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Serge Bologna

37 papers receiving 1.4k citations

Peers

Countries citing papers authored by Serge Bologna

Since Specialization

Citations

This map shows the geographic impact of Serge Bologna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Bologna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Bologna more than expected).

Fields of papers citing papers by Serge Bologna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Bologna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Bologna. The network helps show where Serge Bologna may publish in the future.

Co-authorship network of co-authors of Serge Bologna

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Bologna. A scholar is included among the top collaborators of Serge Bologna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Bologna. Serge Bologna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adrenal lymphoma: presentation, management and prognosis 2016 ·QJM ·Camille Laurent, Olivier Casasnovas, Laurent Martin, Adrien Chauchet, Hervé Ghesquières, (unknown), (unknown), Serge Bologna, Sophie Borot, K. Laurent, Benjamin Bouillet, Bruno Vergès, (unknown)	47
2	Eight Cycles of ABVD Versus Four Cycles of BEACOPP_escalatedPlus Four Cycles of BEACOPP_baselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial 2016 ·Journal of Clinical Oncology ·Patrice Carde, Matthias Karrasch, Catherine Fortpied, Pauline Brice, Hussein Khaled, Olivier Casasnovas, Denis Caillot, Isabelle Gaillard, Serge Bologna, Christophe Fermé, Pieternella J. Lugtenburg, F. Morschhauser, Igor Aurer, Bertrand Coiffier, Ralph M. Meyer, Matthew D. Seftel, Max Wolf, Bengt Glimelius, Anna Sureda, Nicolas Mounier	75
3	ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial 2014 ·Annals of Oncology ·Nicolas Mounier, Pauline Brice, Serge Bologna, Josette Brière, Isabelle Gaillard, (unknown), Jean Gabarre, Olivier Casasnovas, J. Jaubert, Philippe Colin, Alain Delmer, A. Devidas, Emmanuel Bachy, Emmanuelle Nicolas‐Virelizier, (unknown), Catherine Humbrecht, Marc André, Patrice Carde	66
4	Rituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a Lysa Study 2014 ·Blood ·Steven Le Gouill, Catherine Thiéblemont, Lucie Obéric, Krimo Bouabdallah, Emmanuel Gyan, Gandhi Damaj, Vincent Ribrag, Serge Bologna, Rémy Gressin, Olivier Casasnovas, Corinne Haïoun, Philippe Solal‐Céligny, Hervé Maisonneuve, Éric Van Den Neste, Philippe Moreau, Marie C. Béné, Gilles Salles, Hervé Tilly, Thierry Lamy, Olivier Hermine	26
5	Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial 2013 ·The Lancet Oncology ·Richard Delarue, Hervé Tilly, Nicolas Mounier, Tony Petrella, Gilles Salles, Catherine Thiéblemont, Serge Bologna, Hervé Ghesquières, Maya Hacini, Christophe Fruchart, Loïc Ysebaert, Christophe Fermé, Olivier Casasnovas, Achiel Van Hoof, A. Thyss, Alain Delmer, Olivier Fitoussi, Thierry Jo Molina, Corinne Haïoun, André Bosly	205
6	Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial 2013 ·Haematologica ·Nicolas Mounier, Taoufik El Gnaoui, H. Tilly, D. Canioni, Catherine Sebban, Olivier Casasnovas, Richard Delarue, Anne Sonet, Pauline Beaussart, Tony Petrella, Sylvie Castaigné, Serge Bologna, Gilles Salles, Alain Rahmouni, Philippe Gaulard, Corinne Haïoun	112
7	Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B) 2012 ·Annals of Oncology ·Nicolas Ketterer, (unknown), Catherine Thiéblemont, Christophe Fermé, J Brière, Olivier Casasnovas, Serge Bologna, B. Christian, Thierry Connerotte, Christian Récher, Dominique Bordessoule, Christophe Fruchart, Richard Delarue, Christophe Bonnet, F. Morschhauser, Bruno Anglaret, Carole Soussain, Bettina Fabiani, H. Tilly, Corinne Haïoun	21
8	Impact of rituximab on stem cell mobilization following ACVBP regimen in poor‐risk patients with diffuse large B‐cell lymphoma: results from a large cohort of patients 2012 ·Transfusion ·François Lefrère, (unknown), Olivier Héquet, Philippe Bourin, (unknown), A. Bohbot, Hervé Tilly, Gilles Salles, Christophe Fermé, Valérie Lapierre, Luc Mathieu Fornecker, (unknown), (unknown), Serge Bologna, Olivier Fitoussi, Nicolas Mounier, Corinne Haïoun	3
9	Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials 2012 ·Journal of Clinical Oncology ·David Sibon, Marion Fournier, Josette Brière, (unknown), Corinne Haïoun, (unknown), Serge Bologna, Pierre Morel, Jean Gabarre, Olivier Hermine, Anne Sonet, (unknown), (unknown), Philippe Gaulard, Hervé Tilly	126
10	ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial. 2012 ·Journal of Clinical Oncology ·Patrice Carde, Matthias Karrasch, Catherine Fortpied, Pauline Brice, Hussein Khaled, Denis Caillot, Isabelle Gaillard, Serge Bologna, Christophe Fermé, Pieternella J. Lugtenburg, Franck Morschhauser, Igor Aurer, Bertrand Coiffier, Guy Cantin, Matthew D. Seftel, Max Wolf, Bengt Glimelius, Anna Sureda, Nicolas Mounier	25
11	SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma 2011 ·Blood ·Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thiéblemont, Pierre Véra, Serge Bologna, Josette Brière, Jean-Philippe Jaı̈s, Corinne Haïoun, Bertrand Coiffier, Franck Morschhauser	216
12	patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial 2011 ·Annals of Oncology ·Stefano Luminari, Antonella Montanini, Dolores Caballero, Serge Bologna, Michael Notter, Martin J.S. Dyer, Annalisa Chiappella, Javier Briones, Mario Petrini, (unknown), L. Kayitalire, Massimo Federico, (unknown)	1
13	90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Didier Decaudin, Nicolas Mounier, Hervé Tilly, Vincent Ribrag, Hervé Ghesquières, Krimo Bouabdallah, Franck Morschhauser, Bertrand Coiffier, Steven Le Gouill, Serge Bologna, Richard Delarue, Anne Huynh, André Bosly, Josette Brière, Christian Gisselbrecht	39
14	Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial 2009 ·Annals of Oncology ·Stefano Luminari, Antonella Montanini, Dolores Caballero, Serge Bologna, Michael Notter, Martin J.S. Dyer, Annalisa Chiappella, Javier Briones, Mario Petrini, (unknown), L. Kayitalire, Massimo Federico	70
15	Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study. 2009 ·Blood ·Richard Delarue, Corinne Haïoun, Florence Broussais‐Guillaumot, David Sibon, Marion Fournier, Nicolas Mounier, Tony Petrella, Serge Bologna, Christophe Fruchart, Christophe Fermé, Christian Récher, (unknown), Hervé Tilly, André Bosly	2
16	Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial 2007 ·Haematologica ·Mathilde Hunault, (unknown), (unknown), Jean‐Luc Harousseau, Serge Bologna, Chantal Himberlin, D Guyotat, (unknown), P. Casassus, Laurence Baranger, (unknown), Norbert Ifrah, Emmanuel Gyan, (unknown)	25
17	Irradiation fœtale élevée : à propos d'une femme dont la grossesse était méconnue irradiée en sous-diaphragmatique pour un lymphome hodgkinien 2007 ·Cancer/Radiothérapie ·Michel Moreau, (unknown), Serge Bologna, V. Marchesi, S. Hoffstetter, D. Peiffert	1
18	Identification of an Acute Basophilic Leukaemia Carrying a Rare e6a2 BCR-ABL Transcript 2006 ·Acta Haematologica ·Marie‐José Gregoire, Véronique Latger‐Cannard, (unknown), Serge Bologna, (unknown), (unknown), (unknown), Philippe Jonveaux	11
19	[A case of de novo acute basophilic leukaemia: diagnostic criteria and review of the literature]. 2006 ·PubMed ·(unknown), Véronique Latger‐Cannard, (unknown), (unknown), (unknown), Serge Bologna, Brigitte Witz, Philippe Jonveaux, Thomas Lecompte, (unknown)	4
20	Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study). 2002 ·Blood ·Bertrand Coiffier, Nicolas Mounier, Serge Bologna, Christophe Fermé, Raoul Herbrecht, H Tilly, Anne Sonet, B. Christian, Olivier Casasnovas, Éric Jourdan, Karim Belhadj	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact